M.T. Allende

500 total citations
32 papers, 363 citations indexed

About

M.T. Allende is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, M.T. Allende has authored 32 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Surgery. Recurrent topics in M.T. Allende's work include HER2/EGFR in Cancer Research (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Glycosylation and Glycoproteins Research (6 papers). M.T. Allende is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Glycosylation and Glycoproteins Research (6 papers). M.T. Allende collaborates with scholars based in Spain, Portugal and Italy. M.T. Allende's co-authors include Francisco J. Vizoso, María D. Corte‐Torres, J.L. Garcı́a-Muñiz, Miguel Bongera, Luis O. González, José M. del Casar, M L Lamelas, Antonio Fueyo, Juan Carlos Rodrı́guez and Irene Agraz Pamplona and has published in prestigious journals such as British journal of surgery, Breast Cancer Research and Treatment and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

M.T. Allende

31 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.T. Allende Spain 12 132 127 109 74 63 32 363
Alexander G. Raufi United States 11 156 1.2× 275 2.2× 140 1.3× 111 1.5× 125 2.0× 36 457
Yasuhiro Arakawa Japan 11 150 1.1× 159 1.3× 86 0.8× 90 1.2× 94 1.5× 37 380
Kazuaki Yokomizo Japan 12 264 2.0× 148 1.2× 69 0.6× 89 1.2× 112 1.8× 27 431
Ingirídur Skírnisdóttir Sweden 16 176 1.3× 234 1.8× 77 0.7× 77 1.0× 107 1.7× 26 682
Alexander Ws Australia 7 138 1.0× 126 1.0× 88 0.8× 23 0.3× 22 0.3× 9 637
Poh Seng Tan Singapore 12 156 1.2× 67 0.5× 80 0.7× 128 1.7× 124 2.0× 26 541
Marie Pierre Gaub France 8 180 1.4× 124 1.0× 202 1.9× 80 1.1× 118 1.9× 11 430
Jamileh Hashemi Sweden 16 252 1.9× 344 2.7× 49 0.4× 35 0.5× 114 1.8× 26 575
Claudia Augello Italy 13 368 2.8× 83 0.7× 55 0.5× 49 0.7× 196 3.1× 23 570

Countries citing papers authored by M.T. Allende

Since Specialization
Citations

This map shows the geographic impact of M.T. Allende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.T. Allende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.T. Allende more than expected).

Fields of papers citing papers by M.T. Allende

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.T. Allende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.T. Allende. The network helps show where M.T. Allende may publish in the future.

Co-authorship network of co-authors of M.T. Allende

This figure shows the co-authorship network connecting the top 25 collaborators of M.T. Allende. A scholar is included among the top collaborators of M.T. Allende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.T. Allende. M.T. Allende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quintero, Jesús, Jose Andrés Molino, M.T. Allende, et al.. (2024). Sirolimus to treat chronic and steroid‐resistant allograft rejection‐related fibrosis in pediatric liver transplantation. Journal of Pediatric Gastroenterology and Nutrition. 79(5). 962–968.
2.
Izquierdo-Blasco, Jaume, et al.. (2019). Parvovirus B19 Myocarditis: Looking Beyond the Heart. Pediatric and Developmental Pathology. 23(2). 158–162. 7 indexed citations
3.
Zapardiel, Ignacio, et al.. (2015). Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy. International Journal of Gynecological Cancer. 26(1). 52–55. 10 indexed citations
6.
Corte‐Torres, María D., Luis O. González, Sara Junquera, et al.. (2009). Analysis of the expression of hyaluronan in intraductal and invasive carcinomas of the breast. Journal of Cancer Research and Clinical Oncology. 136(5). 745–750. 12 indexed citations
7.
Casar, José M. del, María D. Corte‐Torres, Miguel Bongera, et al.. (2007). Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. Journal of Cancer Research and Clinical Oncology. 134(2). 153–161. 43 indexed citations
8.
Corte‐Torres, María D., et al.. (2005). Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical–pathological parameters and their prognostic significance. Breast Cancer Research and Treatment. 96(1). 63–72. 32 indexed citations
9.
Corte‐Torres, María D., M L Lamelas, Miguel Bongera, et al.. (2005). Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer. The International Journal of Biological Markers. 20(2). 103–111. 27 indexed citations
10.
Corte‐Torres, María D., M L Lamelas, Julio Vázquez, et al.. (2005). Tissue-Type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance. Breast Cancer Research and Treatment. 90(1). 33–40. 21 indexed citations
11.
Vizoso, Francisco J., María D. Corte‐Torres, José M. del Casar, et al.. (2004). Membranous levels of c-erbB-2 oncoprotein in gastric cancer: Their relationship with clinicopathological parameters and their prognostic significance. The International Journal of Biological Markers. 19(4). 268–274. 6 indexed citations
12.
Vizoso, Francisco J., José Carlos Fernández Fernández, María D. Corte‐Torres, et al.. (2004). Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer. Journal of Cancer Research and Clinical Oncology. 130(11). 679–686. 16 indexed citations
13.
Santos‐Juanes, Jorge, et al.. (2004). Apocrine Carcinoma, Adenopathies, and Raised TAG-72 Serum Tumor Marker. Dermatologic Surgery. 30(4). 566–569. 10 indexed citations
14.
Vizoso, Francisco J., et al.. (2003). Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: Clinical significance and relationship with steroid receptors. The International Journal of Biological Markers. 18(4). 301–310. 5 indexed citations
15.
Casar, José M. del, et al.. (2003). Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer. The International Journal of Biological Markers. 18(3). 200–206. 12 indexed citations
16.
Vizoso, Francisco J., et al.. (2002). Análisis del contenido citosólico de la proteína pS2 en el cáncer de mama. Revista Española de Medicina Nuclear. 21(1). 28–33. 4 indexed citations
17.
Gómez, J.M. Fernández, et al.. (2002). [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].. PubMed. 55(1). 41–9. 8 indexed citations
18.
Vizoso, Francisco J., et al.. (2000). C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.. PubMed. 1(6). 483–93. 5 indexed citations
19.
Vizoso, Francisco J., et al.. (2000). c-erbB-2 Oncoprotein Content in Gastric Cancer and in Adjacent Mucosa. The International Journal of Biological Markers. 15(3). 231–234. 8 indexed citations
20.
Vizoso, Francisco J., et al.. (2000). Hyaluronic acid as prognostic marker in resectable colorectal cancer. British journal of surgery. 87(12). 1690–1696. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026